Related Experiment Video
Updated: Jun 3, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Hereditary tumour syndromes featuring basal cell carcinomas
1Department of Dermatology and GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, AZ Maastricht, the Netherlands.
Basal cell carcinoma (BCC), the most common skin cancer, exhibits diverse subtypes and growth patterns. Understanding its genetic basis, particularly in inherited syndromes, is key to developing targeted, non-invasive therapies.
Area of Science:
- Dermatology
- Oncology
- Genetics
Background:
- Basal cell carcinoma (BCC) is the most prevalent skin malignancy globally, presenting diverse histopathological subtypes and growth behaviors.
- BCC can arise sporadically or be associated with genetic syndromes like Gorlin syndrome, highlighting genetic influences on its development.
- Key signaling pathways, including hedgehog and Wnt/β-catenin, are implicated in BCC tumorigenesis.
Purpose of the Study:
- To review the genetic underpinnings of basal cell carcinoma, focusing on its occurrence in inherited tumor syndromes.
- To explore the molecular mechanisms driving BCC development and growth.
- To discuss current therapeutic strategies and future directions for BCC treatment.
Main Methods:
- Literature review of genetic syndromes associated with BCC.
- Analysis of signaling pathways involved in BCC pathogenesis.
- Summary of current and potential future therapeutic approaches for BCC.
Main Results:
- Several genes and signaling pathways, such as hedgehog and Wnt/β-catenin, are crucial in BCC development.
- Genetic defects are identified in some hereditary BCC syndromes, while others remain genetically undefined.
- Current treatments primarily involve surgery, with other options available for superficial BCCs.
Conclusions:
- Elucidating the molecular basis of BCC in genetic syndromes enhances understanding of its complex pathogenesis.
- Further research into molecular mechanisms may lead to novel, non-invasive, and targeted therapeutic strategies for BCC.
- Understanding genetic factors is crucial for advancing personalized medicine in BCC treatment.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

